The biggest study published to date on vitamin C as a treatment for sepsis couldn't say it helped patients. But the paper does hint that people who got the treatment were more likely to survive.
Researchers have devised a large clinical study to quickly assess whether one doctor's apparently effective treatment for deadly sepsis is a fluke or worthy of widespread use.
Two big studies aim to rigorously test what could be a revolutionary treatment for a common and deadly disease: sepsis. Many doctors are awaiting the results before changing their practice.
A bedside computer loaded with software that tracks vital signs in the ICU can pick up early warning patterns, specialists say. But it takes a human care provider to sort the signal from the noise.
A 51-year-old man nearly died from septic shock, when a crushing injury led to overwhelming infection. After getting an experimental treatment, he's recovering well, but some doctors want more proof.
The bodywide inflammation known as sepsis kills about 300,000 people in U.S. hospitals each year. Promising treatments have come and gone, warn skeptical doctors, who call for rigorous research.
